Although AgNP treatments activate p53 in wild type p53-containing osteosarcoma cells, our data indicate that AgNPs can induce mitochondrial stress, which can also drive cancer cell apoptosis in a p53-independent manner. The gene discussed is TP53; the disease is osteosarcoma.